497 related articles for article (PubMed ID: 29786660)
1. Molecular Targets of Active Anticancer Compounds Derived from Marine Sources.
Song X; Xiong Y; Qi X; Tang W; Dai J; Gu Q; Li J
Mar Drugs; 2018 May; 16(5):. PubMed ID: 29786660
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic drugs against cancer: an evolving landscape.
Di Costanzo A; Del Gaudio N; Migliaccio A; Altucci L
Arch Toxicol; 2014 Sep; 88(9):1651-68. PubMed ID: 25085708
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic targets in hematological malignancies: combination therapies with HDACis and demethylating agents.
Bishton M; Kenealy M; Johnstone R; Rasheed W; Prince HM
Expert Rev Anticancer Ther; 2007 Oct; 7(10):1439-49. PubMed ID: 17944568
[TBL] [Abstract][Full Text] [Related]
4. Marine natural products as breast cancer resistance protein inhibitors.
Cherigo L; Lopez D; Martinez-Luis S
Mar Drugs; 2015 Apr; 13(4):2010-29. PubMed ID: 25854646
[TBL] [Abstract][Full Text] [Related]
5. Human Thymidylate Synthase Inhibitors Halting Ovarian Cancer Growth.
Ferrari S; Severi L; Pozzi C; Quotadamo A; Ponterini G; Losi L; Marverti G; Costi MP
Vitam Horm; 2018; 107():473-513. PubMed ID: 29544641
[TBL] [Abstract][Full Text] [Related]
6. Proprotein convertase inhibition: Paralyzing the cell's master switches.
Klein-Szanto AJ; Bassi DE
Biochem Pharmacol; 2017 Sep; 140():8-15. PubMed ID: 28456517
[TBL] [Abstract][Full Text] [Related]
7. Molecular targets in the discovery and development of novel antimetastatic agents: current progress and future prospects.
Wong MS; Sidik SM; Mahmud R; Stanslas J
Clin Exp Pharmacol Physiol; 2013 May; 40(5):307-19. PubMed ID: 23534409
[TBL] [Abstract][Full Text] [Related]
8. MAPK signaling pathway-targeted marine compounds in cancer therapy.
Wei J; Liu R; Hu X; Liang T; Zhou Z; Huang Z
J Cancer Res Clin Oncol; 2021 Jan; 147(1):3-22. PubMed ID: 33389079
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the Anti-Prostate Cancer Properties of Marine-Derived Compounds.
Fan M; Nath AK; Tang Y; Choi YJ; Debnath T; Choi EJ; Kim EK
Mar Drugs; 2018 May; 16(5):. PubMed ID: 29757237
[TBL] [Abstract][Full Text] [Related]
10. Diflomotecan. Ipsen.
Osheroff N
IDrugs; 2004 Mar; 7(3):257-63. PubMed ID: 15011101
[No Abstract] [Full Text] [Related]
11. Marine anticancer drugs and their relevant targets: a treasure from the ocean.
Nigam M; Suleria HAR; Farzaei MH; Mishra AP
Daru; 2019 Jun; 27(1):491-515. PubMed ID: 31165439
[TBL] [Abstract][Full Text] [Related]
12. Sponging off nature for new drug leads.
Andersen RJ
Biochem Pharmacol; 2017 Sep; 139():3-14. PubMed ID: 28411115
[TBL] [Abstract][Full Text] [Related]
13. Inside the biochemical pathways of thymidylate synthase perturbed by anticancer drugs: Novel strategies to overcome cancer chemoresistance.
Taddia L; D'Arca D; Ferrari S; Marraccini C; Severi L; Ponterini G; Assaraf YG; Marverti G; Costi MP
Drug Resist Updat; 2015 Nov; 23():20-54. PubMed ID: 26690339
[TBL] [Abstract][Full Text] [Related]
14. American Association for Cancer Research--100th Annual Meeting. HDAC inhibitors, proteasome inhibitors and vascular disrupting agents. 18-22 April 2009, Denver, CO, USA.
Mitra AP
IDrugs; 2009 Jun; 12(6):339-41. PubMed ID: 19517310
[No Abstract] [Full Text] [Related]
15. Marine Derived Anticancer Drugs Targeting Microtubule.
De O; Chatterji BP
Recent Pat Anticancer Drug Discov; 2017; 12(2):102-127. PubMed ID: 28067173
[TBL] [Abstract][Full Text] [Related]
16. Targeting transcription factors by small compounds--Current strategies and future implications.
Hagenbuchner J; Ausserlechner MJ
Biochem Pharmacol; 2016 May; 107():1-13. PubMed ID: 26686579
[TBL] [Abstract][Full Text] [Related]
17. Microtubule-targeting anticancer agents from marine natural substance.
Liu Z; Xu P; Wu T; Zeng W
Anticancer Agents Med Chem; 2014 Mar; 14(3):409-17. PubMed ID: 24533652
[TBL] [Abstract][Full Text] [Related]
18. Genome-bound enzymes as epigenetic drug targets in cancer.
Bomsztyk K; Wang Y
Epigenomics; 2019 Oct; 11(13):1463-1467. PubMed ID: 31536377
[No Abstract] [Full Text] [Related]
19. A survey of marine natural compounds and their derivatives with anti-cancer activity reported in 2011.
Sawadogo WR; Schumacher M; Teiten MH; Cerella C; Dicato M; Diederich M
Molecules; 2013 Mar; 18(4):3641-73. PubMed ID: 23529027
[TBL] [Abstract][Full Text] [Related]
20. QSAR based docking studies of marine algal anticancer compounds as inhibitors of protein kinase B (PKBβ).
Davis GD; Vasanthi AH
Eur J Pharm Sci; 2015 Aug; 76():110-8. PubMed ID: 25936945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]